Literature DB >> 28917965

The development of a butyrylcholinesterase porous pellet for innovative detection of cholinesterase inhibitors.

Jiří Zeman1, David Vetchý2, Aleš Franc1, Sylvie Pavloková1, Vladimír Pitschmann3, Lukáš Matějovský4.   

Abstract

The aim of the presented research was the preparation of an innovative carrier with significantly improved properties for the fast and sensitive detection of cholinesterase inhibitors such as nerve agents. This innovative carrier was in the form of spherical pellets containing different amounts of Neusilin. Neusilin is a synthetic and amorphous form of magnesium aluminometasilicate with a high specific surface area, and the immobilized enzyme butyrylcholinesterase with an activity of 50nkat·g-1. Pellets were prepared by the extrusion-spheronization method and dried in a hot air oven under two conditions - at 30°C for 72h and at 60°C for 24h. Dried pellets were consequently impregnated with a solution containing butyrylcholinesterase. Impregnated pellets were evaluated for their quality parameters, enzymatic activity and inhibition. Activity and inhibition were tested according to the standard Ellman's method. It was observed that the addition of Neusilin significantly increased the hardness, intraparticular porosity, sphericity and activity of the carriers as well as intensity of the color transition. Therefore it is shown that these carriers have unquestionable advantages over common carriers of their kind. Drying temperatures have been shown to have no effect on properties of pellets except for a change in their size. Results were confirmed by statistical evaluation using ANOVA and PCA.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Detection; Immobilization; Neusilin; Pellets; Physostigmine; Sarin

Mesh:

Substances:

Year:  2017        PMID: 28917965     DOI: 10.1016/j.ejps.2017.09.015

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  2 in total

1.  Technology of Processing Plant Extracts Using an Aluminometasilicate Porous Carrier into a Solid Dosage Form.

Authors:  Klára Kostelanská; Slavomír Kurhajec; Sylvie Pavloková; David Vetchý; Jan Gajdziok; Aleš Franc
Journal:  Pharmaceutics       Date:  2022-01-21       Impact factor: 6.321

2.  Exploration of Neusilin® US2 as an Acceptable Filler in HPMC Matrix Systems-Comparison of Pharmacopoeial and Dynamic Biorelevant Dissolution Study.

Authors:  Tomáš Bílik; Jakub Vysloužil; Martina Naiserová; Jan Muselík; Miroslava Pavelková; Josef Mašek; Drahomíra Čopová; Martin Čulen; Kateřina Kubová
Journal:  Pharmaceutics       Date:  2022-01-05       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.